Clinical trial · Observational
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols
NCT00001503CI-TRIAL-00067311completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
| Melanoma | Melanoma | ONTOLOGY_EXACT | 0.98 |
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- 1/All Patients
- description
- Patients who were previously enrolled on a CCR protocol and need follow-up by CCR Investigators.
Primary outcomes (1)
- measure
- To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol
- timeFrame
- 30 years
- description
- Provision of a mechanism to follow selected CCR patients when their protocols have been terminated.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Month
Show eligibility criteria text
* ELIGIBILITY CRITERIA: Patients of any age who were previously enrolled on a CCR protocol. Not eligible for or unwilling to participate in an active NCI intramural primary research protocol. CCR investigator decides it is in the best interests of the patient and the CC for the patient to be seen in follow-up visits at the NIH. Patient or Legally Authorized Representative (LAR)/guardian is able to provide informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.